$SSKN
STRATA Skin Sciences, Inc.

2014 Q4 Form 10-Q Financial Statement

#000119312514411625 Filed on November 14, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $370.0K $217.9K $107.7K
YoY Change 164.29% 102.31% 55.81%
Cost Of Revenue $1.180M $1.560M $1.977M
YoY Change -1280.0% -21.1% 247.43%
Gross Profit -$810.0K -$1.342M -$1.869M
YoY Change -437.5% -28.21% 273.93%
Gross Profit Margin -218.92% -615.69% -1735.07%
Selling, General & Admin $2.610M $2.315M $3.481M
YoY Change -15.81% -33.5% 0.31%
% of Gross Profit
Research & Development $220.0K $344.5K $856.8K
YoY Change -59.26% -59.79% -38.74%
% of Gross Profit
Depreciation & Amortization $420.0K $488.0K $681.8K
YoY Change -35.38% -28.42% 172.7%
% of Gross Profit
Operating Expenses $2.830M $2.659M $4.337M
YoY Change -22.25% -38.69% 210.15%
Operating Profit -$3.640M -$4.001M -$6.206M
YoY Change 7.06% -35.54% 15.62%
Interest Expense -$890.0K $530.5K $222.8K
YoY Change 323.81% 138.17% 2127.58%
% of Operating Profit
Other Income/Expense, Net $20.00K $1.713M -$1.198M
YoY Change 100.0% -242.96% -24286.11%
Pretax Income -$4.500M -$2.290M -$7.400M
YoY Change -2.39% -69.05% 38.06%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.500M -$2.288M -$7.404M
YoY Change -2.39% -69.1% 38.22%
Net Earnings / Revenue -1216.22% -1049.95% -6874.6%
Basic Earnings Per Share -$0.44 -$1.72
Diluted Earnings Per Share -$3.846M -$0.44 -$1.72
COMMON SHARES
Basic Shares Outstanding 6.037M shares 5.216M shares 4.312M shares
Diluted Shares Outstanding 5.216M shares 4.312M shares

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.43M $14.47M $2.620M
YoY Change 202.38% 452.29% -80.27%
Cash & Equivalents $11.43M $14.47M $2.620M
Short-Term Investments
Other Short-Term Assets $270.0K $620.0K $670.0K
YoY Change -69.32% -7.46% 8.06%
Inventory $5.275M $5.364M $271.6K
Prepaid Expenses
Receivables $220.0K $85.23K $50.92K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.20M $20.53M $3.608M
YoY Change 66.2% 469.1% -75.37%
LONG-TERM ASSETS
Property, Plant & Equipment $1.961M $2.713M $9.418M
YoY Change -46.87% -71.19% 79.74%
Goodwill
YoY Change
Intangibles $37.00K $37.99K $43.06K
YoY Change -11.9% -11.79%
Long-Term Investments
YoY Change
Other Assets $48.00K $48.00K $80.13K
YoY Change 0.0% -40.1% -57.83%
Total Long-Term Assets $2.867M $3.781M $9.542M
YoY Change -24.17% -60.37% 73.8%
TOTAL ASSETS
Total Short-Term Assets $17.20M $20.53M $3.608M
Total Long-Term Assets $2.867M $3.781M $9.542M
Total Assets $20.07M $24.31M $13.15M
YoY Change 42.02% 84.9% -34.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.240M $1.272M $1.425M
YoY Change -16.16% -10.73% 11.31%
Accrued Expenses $842.0K $1.011M $878.5K
YoY Change -0.24% 15.04% -3.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.686M $3.953M $2.629M
YoY Change -52.48% 50.39% 11.38%
LONG-TERM LIABILITIES
Long-Term Debt $5.000M $5.030M $0.00
YoY Change
Other Long-Term Liabilities $610.0K $100.0K $230.0K
YoY Change 238.89% -56.52% 9.52%
Total Long-Term Liabilities $5.108M $5.136M $231.3K
YoY Change 2676.09% 2120.38% 10.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.686M $3.953M $2.629M
Total Long-Term Liabilities $5.108M $5.136M $231.3K
Total Liabilities $7.794M $9.089M $2.860M
YoY Change 33.55% 217.82% 11.28%
SHAREHOLDERS EQUITY
Retained Earnings -$182.3M -$177.8M -$163.5M
YoY Change 8.41% 8.71%
Common Stock $194.6M $193.0M $173.8M
YoY Change 10.27% 11.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.28M $15.22M $10.29M
YoY Change
Total Liabilities & Shareholders Equity $20.07M $24.31M $13.15M
YoY Change 42.02% 84.9% -34.71%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$4.500M -$2.288M -$7.404M
YoY Change -2.39% -69.1% 38.22%
Depreciation, Depletion And Amortization $420.0K $488.0K $681.8K
YoY Change -35.38% -28.42% 172.7%
Cash From Operating Activities -$3.040M -$3.630M -$5.000M
YoY Change -22.05% -27.4% 0.81%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$1.100M
YoY Change -100.0% -100.0% -51.75%
Acquisitions
YoY Change
Other Investing Activities $0.00 $10.00K
YoY Change
Cash From Investing Activities $0.00 $10.00K -$1.100M
YoY Change -100.0% -100.91% -51.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 10.00K 13.88M -6.420M
YoY Change -99.81% -316.2% -294.55%
NET CHANGE
Cash From Operating Activities -3.040M -3.630M -5.000M
Cash From Investing Activities 0.000 10.00K -1.100M
Cash From Financing Activities 10.00K 13.88M -6.420M
Net Change In Cash -3.030M 10.26M -12.52M
YoY Change -361.21% -181.95% 217.77%
FREE CASH FLOW
Cash From Operating Activities -$3.040M -$3.630M -$5.000M
Capital Expenditures $0.00 $0.00 -$1.100M
Free Cash Flow -$3.040M -$3.630M -$3.900M
YoY Change -15.08% -6.92% 45.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 mela Common Stock Minimum Bid Price
CommonStockMinimumBidPrice
1.00
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6037232 shares
CY2013Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5300000
CY2013Q1 mela Fair Value Of Warrant Obligation
FairValueOfWarrantObligation
563000
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5213969 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Senior Long Term Notes
SeniorLongTermNotes
4647082
CY2014Q3 mela Fair Value Of Warrant Obligation
FairValueOfWarrantObligation
5296345
CY2014Q3 mela Fair Value Of Warrants Issued
FairValueOfWarrantsIssued
491228
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2620291
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
422819 shares
CY2014Q3 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
1.72
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
12300 shares
CY2014Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
13078920 shares
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
1230
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5217742 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5217742 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
12300 shares
CY2014Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
134072
CY2014Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1401333
CY2014Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
13725
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5277110
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3953014
CY2014Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5136259
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
5218
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1271877
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-177789288
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
193007017
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1010666
CY2014Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
70711
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
15224177
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24313450
CY2014Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0
CY2014Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1451121
CY2014Q3 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
493715
CY2014Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
85278
CY2014Q3 us-gaap Liabilities
Liabilities
9089273
CY2014Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
90093
CY2014Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
5032441
CY2014Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
43080
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14466227
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2713083
CY2014Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
617185
CY2014Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
727000
CY2014Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7990193
CY2014Q3 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
981950
CY2014Q3 us-gaap Assets
Assets
24313450
CY2014Q3 us-gaap Inventory Gross
InventoryGross
6765120
CY2014Q3 us-gaap Inventory Net
InventoryNet
5363787
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
85230
CY2014Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
37988
CY2014Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48000
CY2014Q3 us-gaap Assets Current
AssetsCurrent
20532429
CY2014Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
9967564
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7861524
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4750160 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4750160 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2013Q4 us-gaap Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
6.40
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
67934
CY2013Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
325000
CY2013Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
63754
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5403414
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5651807
CY2013Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
183874
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
4750
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1478995
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-168147878
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
176438961
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
844131
CY2013Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
32902
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
8295833
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14131514
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
48000
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
3017142
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
243605
CY2013Q4 us-gaap Liabilities
Liabilities
5835681
CY2013Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
120120
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
46130
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3782881
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3690784
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
879698
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9094198
CY2013Q4 us-gaap Assets
Assets
14131514
CY2013Q4 us-gaap Inventory Gross
InventoryGross
5956205
CY2013Q4 us-gaap Inventory Net
InventoryNet
5631205
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
57151
CY2013Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
41795
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
10350935
CY2013Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
0
CY2013Q3 mela Consecutive Business Period Not Complied With Minimum Bid Price
ConsecutiveBusinessPeriodNotCompliedWithMinimumBidPrice
P30D
CY2014Q3 mela Number Of Unfulfilled Purchase Orders
NumberOfUnfulfilledPurchaseOrders
2 PurchaseOrder
CY2014Q2 mela Additional Liquidation Damages Payable
AdditionalLiquidationDamagesPayable
500000
CY2014Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.1 pure
CY2014Q3 mela Effective Date Of Stock Split
EffectiveDateOfStockSplit
2014-07-10
CY2014Q3 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
5847955 shares
CY2014Q3 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
4565350
CY2014Q3 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
15000005
CY2014Q3 mela Term Loan And Security Agreement Date
TermLoanAndSecurityAgreementDate
2014-07-21
CY2014Q3 mela Closing Date Of Agreement
ClosingDateOfAgreement
2014-07-24
CY2013Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
983330
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7171 pure
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-15513449
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0071 pure
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4182814 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7683 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0204 pure
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
344956 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4182814 shares
us-gaap Gross Profit
GrossProfit
-4042005
us-gaap Sales Revenue Net
SalesRevenueNet
396206
us-gaap Repayments Of Debt
RepaymentsOfDebt
6425000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-300528
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-4000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-79014
us-gaap Operating Income Loss
OperatingIncomeLoss
-19724189
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1613609
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15400
us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
-89859
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4865358
us-gaap Net Income Loss
NetIncomeLoss
-21337798
us-gaap Investment Income Interest
InvestmentIncomeInterest
7323
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-76944
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
69364
us-gaap Interest Expense
InterestExpense
563143
us-gaap Operating Expenses
OperatingExpenses
15682184
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3241727
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12440457
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
41166
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
163569
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-17739
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-5241233
us-gaap Cost Of Revenue
CostOfRevenue
4438211
us-gaap Depreciation
Depreciation
1785793
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1790037
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
86042
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15137574
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15789873
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4865358
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18059
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-503345
us-gaap Share Based Compensation
ShareBasedCompensation
1256754
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
1010712
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
17017
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
6000000
mela Bad Debt Expense
BadDebtExpense
52097
mela Provision For Inventory Reserve
ProvisionForInventoryReserve
325000
mela Amount Reclassified From Warrant Liability To Equity
AmountReclassifiedFromWarrantLiabilityToEquity
652442
mela Write Off Of Unamortized Loan Costs
WriteOffOfUnamortizedLoanCosts
983330
mela Payments For Borrowings And Warrant Exercises
PaymentsForBorrowingsAndWarrantExercises
245358
us-gaap Debt Instrument Convertible Remaining Discount Amortization Period1
DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1
P5Y
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.89
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.7551 pure
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
MELA SCIENCES, INC. /NY
dei Trading Symbol
TradingSymbol
MELA
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
us-gaap Derivative Inception Dates
DerivativeInceptionDates
2014-02-05
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14668421
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
In July 2014, the Company effected a one-for-ten reverse split of its common stock
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9346 pure
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5108418 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
us-gaap Registration Payment Arrangement Event To Transfer Consideration
RegistrationPaymentArrangementEventToTransferConsideration
Under the terms of the Registration Rights Agreement, the Company filed a registration statement on March 18, 2014, which was declared effective by the SEC on April 3, 2014. Should this registration statement cease to remain effective for more than ten consecutive calendar days or more than an aggregate of 15 calendar days during any 12-month period, the Company would be subject to additional liquidated damages of up to approximately $500,000.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0214 pure
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5108418 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.89
us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0176 pure
dei Entity Central Index Key
EntityCentralIndexKey
0001051514
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.26
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.7387 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0245 pure
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
24042545 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5108418 shares
us-gaap Gross Profit
GrossProfit
-3214391
us-gaap Sales Revenue Net
SalesRevenueNet
540695
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-262513
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1362391
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
4565350
us-gaap Operating Income Loss
OperatingIncomeLoss
-12991181
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
15740
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
0
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3349771
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
130562
us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
7150886
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11528774
us-gaap Net Income Loss
NetIncomeLoss
-9641410
us-gaap Investment Income Interest
InvestmentIncomeInterest
5180
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
28779
us-gaap Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction
DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction
5787573
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-208356
us-gaap Interest Expense
InterestExpense
532899
us-gaap Operating Expenses
OperatingExpenses
9776790
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1422997
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
8353793
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
37689
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-30027
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10683346
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2523427
us-gaap Convertible Preferred Stock Converted To Other Securities
ConvertiblePreferredStockConvertedToOtherSecurities
1887364
us-gaap Cost Of Revenue
CostOfRevenue
3755086
us-gaap Depreciation
Depreciation
1366995
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1370802
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
25334767
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11457831
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
385359
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3480689
CY2013Q3 us-gaap Cost Of Revenue
CostOfRevenue
1976501
CY2013Q3 us-gaap Depreciation
Depreciation
681759
CY2013Q3 us-gaap Share Based Compensation
ShareBasedCompensation
159621
CY2013Q3 mela Write Off Of Unamortized Loan Costs
WriteOffOfUnamortizedLoanCosts
983330
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.44
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
12300000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
17000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
17000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-40583
us-gaap Share Based Compensation
ShareBasedCompensation
447295
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
66138
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
15000005
mela Bad Debt Expense
BadDebtExpense
700
CY2013Q3 us-gaap Interest Expense
InterestExpense
222758
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
4337453
mela Fair Value Assumptions Treasury Yield Period
FairValueAssumptionsTreasuryYieldPeriod
P5Y
mela Registration Rights Liquidating Damages
RegistrationRightsLiquidatingDamages
3419698
mela Provision For Inventory Reserve
ProvisionForInventoryReserve
1076333
mela Increase Decrease In Property Plant And Equipment
IncreaseDecreaseInPropertyPlantAndEquipment
-162922
mela Payments For Borrowings And Warrant Exercises
PaymentsForBorrowingsAndWarrantExercises
1123069
CY2014Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
11500000
CY2014Q3 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
13800000
CY2013 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P5Y3M29D
CY2013 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9343 pure
CY2013 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0175 pure
CY2013 mela Fair Value Assumptions Treasury Yield Period
FairValueAssumptionsTreasuryYieldPeriod
P5Y
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.72
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4312118 shares
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.72
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4312118 shares
CY2013Q3 us-gaap Gross Profit
GrossProfit
-1868794
CY2013Q3 us-gaap Sales Revenue Net
SalesRevenueNet
107707
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6206247
CY2013Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1198180
CY2013Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5400
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-7404427
CY2013Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2508
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
856764
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5216290 shares
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5216290 shares
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.44
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.80
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5216290 shares
CY2014Q3 us-gaap Gross Profit
GrossProfit
-1341600
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
217902
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4000837
CY2014Q3 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
11000
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1712975
CY2014Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
120537
CY2014Q3 us-gaap Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss
FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
2108106
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4175226
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-2287862
CY2014Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
3874
CY2014Q3 us-gaap Interest Expense
InterestExpense
530542
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
2659237
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
344525
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2314712
CY2014Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-671999
CY2014Q3 us-gaap Cost Of Revenue
CostOfRevenue
1559502
CY2014Q3 us-gaap Depreciation
Depreciation
487998
CY2014Q3 us-gaap Share Based Compensation
ShareBasedCompensation
115180

Files In Submission

Name View Source Status
0001193125-14-411625-index-headers.html Edgar Link pending
0001193125-14-411625-index.html Edgar Link pending
0001193125-14-411625.txt Edgar Link pending
0001193125-14-411625-xbrl.zip Edgar Link pending
d801327d10q.htm Edgar Link pending
d801327dex101.htm Edgar Link pending
d801327dex102.htm Edgar Link pending
d801327dex103.htm Edgar Link pending
d801327dex311.htm Edgar Link pending
d801327dex312.htm Edgar Link pending
d801327dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mela-20140930.xml Edgar Link completed
mela-20140930.xsd Edgar Link pending
mela-20140930_cal.xml Edgar Link unprocessable
mela-20140930_def.xml Edgar Link unprocessable
mela-20140930_lab.xml Edgar Link unprocessable
mela-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending